REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 28 filers reported holding REGULUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $552,000 | -5.3% | 1,851,851 | 0.0% | 0.05% | +4.0% |
| Q4 2021 | $583,000 | -54.4% | 1,851,851 | 0.0% | 0.05% | -50.0% |
| Q3 2021 | $1,279,000 | -15.1% | 1,851,851 | 0.0% | 0.10% | -16.7% |
| Q2 2021 | $1,506,000 | -47.9% | 1,851,851 | 0.0% | 0.12% | -56.7% |
| Q1 2021 | $2,888,000 | +15.6% | 1,851,851 | 0.0% | 0.28% | +8.6% |
| Q4 2020 | $2,499,000 | +162.8% | 1,851,851 | 0.0% | 0.26% | +127.7% |
| Q3 2020 | $951,000 | -24.6% | 1,851,851 | 0.0% | 0.11% | -20.0% |
| Q2 2020 | $1,262,000 | +47.9% | 1,851,851 | 0.0% | 0.14% | +28.4% |
| Q1 2020 | $853,000 | -48.2% | 1,851,851 | 0.0% | 0.11% | -20.4% |
| Q4 2019 | $1,648,000 | +23.6% | 1,851,851 | 0.0% | 0.14% | -18.0% |
| Q3 2019 | $1,333,000 | -42.4% | 1,851,851 | 0.0% | 0.17% | -42.0% |
| Q2 2019 | $2,314,000 | – | 1,851,851 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,851,851 | $951,000 | 0.11% |
| BVF INC/IL | 3,217,480 | $1,654,000 | 0.09% |
| NEA Management Company, LLC | 2,052,455 | $1,055,000 | 0.04% |
| McGuire Investment Group, LLC | 24,000 | $12,000 | 0.00% |
| WEDBUSH SECURITIES INC | 70,204 | $36,000 | 0.00% |
| GRIMES & COMPANY, INC. | 23,998 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,200 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,347 | $33,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 49,497 | $25,000 | 0.00% |